Skip to main content

Table 3 Characteristics of patients related to adherence

From: Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer

 

Primary non-adherent (%)

Secondary non-adherent (%)

Adherent (%)

P-value

2 Pearson’s)

Tumor stage

 T1

83 (82.2)

95 (50.5)

508 (56.3)

< 0.001

 T2

14 (13.9)

67 (35.6)

275 (30.5)

 

 T3-T4

2 (2.0)

2 (1.1)

28 (3.1)

 

 Unknown

2 (2.0)

24 (12.8)

92 (10.2)

 

Histological grade

 Grade 1

3 (3.0)

25 (13.3)

76 (8.4)

< 0.001

 Grade 2

87 (86.1)

92 (48.9)

507 (56.1)

 

 Grade 3

10 (9.9)

46 (24.5)

229 (25.4)

 

 Unknown

1 (1.0)

25 (13.3)

91 (10.1)

 

Axillary lymph node metastasis

 0

90 (89.1)

102 (54.3)

473 (52.4)

< 0.001

 1-3

7 (6.9)

47 (25.0)

280 (31.0)

 

  ≥ 4

1 (1.0)

23 (12.2)

119 (13.2)

 

 Unknown

3 (3.0)

16 (8.5)

31 (3.4)

 

Radiation

 No

39 (38.6)

72 (38.3)

234 (25.9)

< 0.001

 Yes

62 (61.4)

116 (61.7)

669 (74.1)

 

Chemotherapy

 No

96 (95.0)

101 (53.7)

379 (42.0)

< 0.001

 Yes

5 (5.0)

87 (46.3)

524 (58.0)

 

Neoadjuvant treatment

 No

99 (98.0)

154 (81.9)

764 (84.6)

< 0.001

 Yes

2 (2.0)

34 (18.1)

139 (15.4)